Ursal, Mary Jane .
HRN: 07-44-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2024
CEFUROXIME 1.5GM (VIAL)
03/25/2024
03/25/2024
IVT
1.5
On Call To OR
Pre-Op Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes